At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01167 JACOBIO-B
Market Closed 05-22 16:08:22
5.320
+0.020
+0.38%
High5.400
Low5.230
Vol924.00K
Open5.390
D1 Closing5.300
Amplitude3.21%
Mkt Cap4.17B
Tradable Cap4.17B
Total Shares784.00M
T/O4.90M
T/O Rate0.12%
Tradable Shares784.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JACOBIO-B repurchases 87,300 shares for HK$0.46 million; treasury stock rises to 7.50 million shares
Jacobio Pharmaceuticals Group Co Ltd is an investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-21822 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly operates its businesses in China market.